Status:
TERMINATED
Measurements to Assess Severity of Epicardial Stenoses
Lead Sponsor:
University of Cincinnati
Collaborating Sponsors:
American Heart Association
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Newly developed diagnostic parameters have potential to differentiate between epicardial disease and microvascular dysfunction with the help of anatomical details and physiological endpoints and can b...
Detailed Description
The pressure drop coefficient (CDP) is a functional index based on hyperemic dp and u measurements. The lesion flow coefficient (LFC) combines the functional index CDP with an atomic measure (percenta...
Eligibility Criteria
Inclusion
- Abnormal Myocardial stress perfusion (SPECT) LV EF \> 25%
Exclusion
- LV \< or + to 25% Serum Creatinine \> 2.5 gm/dL Type II HIT Significant co-morbidities Pregnant women
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00760630
Start Date
December 1 2009
End Date
February 24 2012
Last Update
December 27 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Cincinnati, Ohio, United States, 45219
2
Department of Veterans Affairs
Cincinnati, Ohio, United States, 45220